News headlines Altimmune is gaining attention as insiders show confidence through recent share purchases, and positive trial results for its lead candidate, pemvidutide, suggest significant future ...
Chart does not reflect overnight price.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback